Amendment, dated April 28, 2022, to Joint Operating Agreement, dated August 6, 2021, by and among European Wellness Biomedical Group, Bio Peptides LLC and the Registrant
Contract Categories:
Business Operations
- Operating Agreements
EX-10.32 38 ex10-32.htm
Exhibit 10.32
Confidential
In witness WHEREOF as of April 28, 2022, the parties have executed this Joint Agreement Amendment #1 for operations for Vitro Biopharma and the European Wellness Group/Biopep.
VITRO BIOPHARMA, INC.
| By: | /s/ Nathan Haas | |
| Name: | Nathan Haas NH. 5.12.22 | |
| Title: | Chief Financial Officer |
EUROPEAN WELLNESS/ BIOPEP
| By: | /s/ Dr. Mike Chan Kok Seng | |
| Name: | Dr. Mike Chan Kok Seng | |
| (Tan Kor Seng ) Passport #A53952903 | ||
| Title: | President and Chief Executive Officer | |
BIOPEP ( A subsidiary of European Wellness)
| By: | /s/Dr.Desiree Cox-Maksimov | |
| Name: | Dr. Desiree Cox – Maksimov MD, PHD | |
| Title: | CEO BioPep |
| 6 | Page |
